Lincoln Pharmaceuticals has successfully launched a cough syrup ‘NAMCOLD-DX’, which contains Dextromethorphan Polistirex. This is an Extended Release, unique product of Novel Technology. ‘NAMCOLD-DX’ is designed for all age group of patient above 4 years. The product is time tested and many trials have been done and it is approved by Drug Controller General of India (DCGI).
Normal cough syrups are effective up to 3-4 hours, so in 24 hours the patient has to take the syrup 4 to 5 times. But, this innovative product ‘NAMCOLD-DX’ is extended release, so the drug releases periodically and therefore the patient has to take only 2 doses during 24 hours.
Lincoln Pharmaceuticals is a company is based at Ahmedabad and engaged in Manufacturing and Export of Pharmaceuticals formulations under various Therapeutic product group, plant duly complied with WHO-GMP guidelines. The Company is exporting more than 45 countries along with Domestic market in more than 20 states in India.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: